Professor Leonid Churilov is a clinical biostatistician who led complex and comprehensive design and analysis of acute and recovery stroke trials that resulted in global changes in clinical practice, and are internationally recognized through multiple publications in the highest impact medical journals including NEJM, The Lancet and JAMA.

Professor Churilov led the development, and wide adoption by the Australian stroke clinical community, of novel clinical trial designs, original analytical approaches and outcome measurements from “bench-to-bedside”. His decision-modelling effort provided analytical underpinnings for acute stroke processes of care adopted both nationally and internationally, including the activities of the first Australian stroke ambulance.